nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Venous thrombosis—Capecitabine—colon cancer	0.012	0.012	CcSEcCtD
Gadodiamide—Myocardial ischaemia—Fluorouracil—colon cancer	0.0115	0.0115	CcSEcCtD
Gadodiamide—Extravasation—Vincristine—colon cancer	0.0114	0.0114	CcSEcCtD
Gadodiamide—Extravasation—Irinotecan—colon cancer	0.0111	0.0111	CcSEcCtD
Gadodiamide—Vasodilation procedure—Irinotecan—colon cancer	0.011	0.011	CcSEcCtD
Gadodiamide—Vasodilation—Irinotecan—colon cancer	0.011	0.011	CcSEcCtD
Gadodiamide—Extravasation—Fluorouracil—colon cancer	0.0106	0.0106	CcSEcCtD
Gadodiamide—Encephalopathy—Capecitabine—colon cancer	0.0101	0.0101	CcSEcCtD
Gadodiamide—Coma—Vincristine—colon cancer	0.00907	0.00907	CcSEcCtD
Gadodiamide—Coma—Fluorouracil—colon cancer	0.00846	0.00846	CcSEcCtD
Gadodiamide—Rash erythematous—Capecitabine—colon cancer	0.00845	0.00845	CcSEcCtD
Gadodiamide—Myocardial ischaemia—Capecitabine—colon cancer	0.00805	0.00805	CcSEcCtD
Gadodiamide—Ageusia—Capecitabine—colon cancer	0.00798	0.00798	CcSEcCtD
Gadodiamide—Injection site pain—Capecitabine—colon cancer	0.00792	0.00792	CcSEcCtD
Gadodiamide—Rigors—Capecitabine—colon cancer	0.00792	0.00792	CcSEcCtD
Gadodiamide—Renal failure acute—Irinotecan—colon cancer	0.0076	0.0076	CcSEcCtD
Gadodiamide—Encephalopathy—Methotrexate—colon cancer	0.0075	0.0075	CcSEcCtD
Gadodiamide—Visual disturbance—Irinotecan—colon cancer	0.0074	0.0074	CcSEcCtD
Gadodiamide—Renal impairment—Irinotecan—colon cancer	0.00737	0.00737	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Irinotecan—colon cancer	0.00725	0.00725	CcSEcCtD
Gadodiamide—Hyponatraemia—Vincristine—colon cancer	0.00723	0.00723	CcSEcCtD
Gadodiamide—Hyponatraemia—Irinotecan—colon cancer	0.00704	0.00704	CcSEcCtD
Gadodiamide—Cardiac failure—Fluorouracil—colon cancer	0.00688	0.00688	CcSEcCtD
Gadodiamide—Lung disorder—Methotrexate—colon cancer	0.0068	0.0068	CcSEcCtD
Gadodiamide—Ataxia—Vincristine—colon cancer	0.00677	0.00677	CcSEcCtD
Gadodiamide—Coordination abnormal—Capecitabine—colon cancer	0.00659	0.00659	CcSEcCtD
Gadodiamide—Blood creatinine increased—Irinotecan—colon cancer	0.00657	0.00657	CcSEcCtD
Gadodiamide—Injection site reaction—Capecitabine—colon cancer	0.00643	0.00643	CcSEcCtD
Gadodiamide—Melaena—Capecitabine—colon cancer	0.00632	0.00632	CcSEcCtD
Gadodiamide—Ataxia—Fluorouracil—colon cancer	0.00632	0.00632	CcSEcCtD
Gadodiamide—Sweating increased—Irinotecan—colon cancer	0.00591	0.00591	CcSEcCtD
Gadodiamide—Abnormal vision—Capecitabine—colon cancer	0.00564	0.00564	CcSEcCtD
Gadodiamide—Extravasation—Methotrexate—colon cancer	0.00552	0.00552	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Vincristine—colon cancer	0.00547	0.00547	CcSEcCtD
Gadodiamide—Phlebitis—Capecitabine—colon cancer	0.00545	0.00545	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Vincristine—colon cancer	0.00544	0.00544	CcSEcCtD
Gadodiamide—Myocardial infarction—Vincristine—colon cancer	0.00544	0.00544	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Irinotecan—colon cancer	0.00533	0.00533	CcSEcCtD
Gadodiamide—Renal failure—Irinotecan—colon cancer	0.00531	0.00531	CcSEcCtD
Gadodiamide—Myocardial infarction—Irinotecan—colon cancer	0.0053	0.0053	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Fluorouracil—colon cancer	0.0051	0.0051	CcSEcCtD
Gadodiamide—Hepatic enzyme increased—Methotrexate—colon cancer	0.00509	0.00509	CcSEcCtD
Gadodiamide—Renal failure acute—Capecitabine—colon cancer	0.00508	0.00508	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Fluorouracil—colon cancer	0.00507	0.00507	CcSEcCtD
Gadodiamide—Myocardial infarction—Fluorouracil—colon cancer	0.00507	0.00507	CcSEcCtD
Gadodiamide—Hot flush—Capecitabine—colon cancer	0.00502	0.00502	CcSEcCtD
Gadodiamide—Menopausal symptoms—Capecitabine—colon cancer	0.00498	0.00498	CcSEcCtD
Gadodiamide—Hallucination—Vincristine—colon cancer	0.00496	0.00496	CcSEcCtD
Gadodiamide—Renal impairment—Capecitabine—colon cancer	0.00493	0.00493	CcSEcCtD
Gadodiamide—Urinary tract disorder—Vincristine—colon cancer	0.00492	0.00492	CcSEcCtD
Gadodiamide—Urethral disorder—Vincristine—colon cancer	0.00488	0.00488	CcSEcCtD
Gadodiamide—Rhinitis—Irinotecan—colon cancer	0.00486	0.00486	CcSEcCtD
Gadodiamide—Cardiac failure—Capecitabine—colon cancer	0.00481	0.00481	CcSEcCtD
Gadodiamide—Hyponatraemia—Capecitabine—colon cancer	0.00471	0.00471	CcSEcCtD
Gadodiamide—Melaena—Methotrexate—colon cancer	0.0047	0.0047	CcSEcCtD
Gadodiamide—Visual impairment—Irinotecan—colon cancer	0.00468	0.00468	CcSEcCtD
Gadodiamide—Rhinitis—Fluorouracil—colon cancer	0.00466	0.00466	CcSEcCtD
Gadodiamide—Migraine—Capecitabine—colon cancer	0.00462	0.00462	CcSEcCtD
Gadodiamide—Pharyngitis—Fluorouracil—colon cancer	0.00461	0.00461	CcSEcCtD
Gadodiamide—Flushing—Irinotecan—colon cancer	0.0045	0.0045	CcSEcCtD
Gadodiamide—Ataxia—Capecitabine—colon cancer	0.00441	0.00441	CcSEcCtD
Gadodiamide—Coma—Methotrexate—colon cancer	0.0044	0.0044	CcSEcCtD
Gadodiamide—Blood creatinine increased—Capecitabine—colon cancer	0.0044	0.0044	CcSEcCtD
Gadodiamide—Chills—Irinotecan—colon cancer	0.00435	0.00435	CcSEcCtD
Gadodiamide—Arrhythmia—Irinotecan—colon cancer	0.00433	0.00433	CcSEcCtD
Gadodiamide—Arrhythmia—Fluorouracil—colon cancer	0.00415	0.00415	CcSEcCtD
Gadodiamide—Bronchospasm—Capecitabine—colon cancer	0.00399	0.00399	CcSEcCtD
Gadodiamide—Sweating increased—Capecitabine—colon cancer	0.00395	0.00395	CcSEcCtD
Gadodiamide—Ill-defined disorder—Irinotecan—colon cancer	0.00392	0.00392	CcSEcCtD
Gadodiamide—Malaise—Irinotecan—colon cancer	0.00381	0.00381	CcSEcCtD
Gadodiamide—Syncope—Irinotecan—colon cancer	0.00379	0.00379	CcSEcCtD
Gadodiamide—Renal failure acute—Methotrexate—colon cancer	0.00379	0.00379	CcSEcCtD
Gadodiamide—Convulsion—Vincristine—colon cancer	0.00376	0.00376	CcSEcCtD
Gadodiamide—Loss of consciousness—Irinotecan—colon cancer	0.00371	0.00371	CcSEcCtD
Gadodiamide—Myalgia—Vincristine—colon cancer	0.00369	0.00369	CcSEcCtD
Gadodiamide—Visual disturbance—Methotrexate—colon cancer	0.00369	0.00369	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Methotrexate—colon cancer	0.00361	0.00361	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Capecitabine—colon cancer	0.00357	0.00357	CcSEcCtD
Gadodiamide—Renal failure—Capecitabine—colon cancer	0.00356	0.00356	CcSEcCtD
Gadodiamide—Discomfort—Irinotecan—colon cancer	0.00355	0.00355	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Capecitabine—colon cancer	0.00355	0.00355	CcSEcCtD
Gadodiamide—Myocardial infarction—Capecitabine—colon cancer	0.00355	0.00355	CcSEcCtD
Gadodiamide—Anaphylactic shock—Vincristine—colon cancer	0.00354	0.00354	CcSEcCtD
Gadodiamide—Oedema—Vincristine—colon cancer	0.00354	0.00354	CcSEcCtD
Gadodiamide—Infection—Vincristine—colon cancer	0.00352	0.00352	CcSEcCtD
Gadodiamide—Convulsion—Fluorouracil—colon cancer	0.00351	0.00351	CcSEcCtD
Gadodiamide—Nervous system disorder—Vincristine—colon cancer	0.00347	0.00347	CcSEcCtD
Gadodiamide—Oedema—Irinotecan—colon cancer	0.00345	0.00345	CcSEcCtD
Gadodiamide—Anaphylactic shock—Irinotecan—colon cancer	0.00345	0.00345	CcSEcCtD
Gadodiamide—Chest pain—Fluorouracil—colon cancer	0.00344	0.00344	CcSEcCtD
Gadodiamide—Myalgia—Fluorouracil—colon cancer	0.00344	0.00344	CcSEcCtD
Gadodiamide—Infection—Irinotecan—colon cancer	0.00342	0.00342	CcSEcCtD
Gadodiamide—Hyperhidrosis—Vincristine—colon cancer	0.00342	0.00342	CcSEcCtD
Gadodiamide—Discomfort—Fluorouracil—colon cancer	0.0034	0.0034	CcSEcCtD
Gadodiamide—Shock—Irinotecan—colon cancer	0.00339	0.00339	CcSEcCtD
Gadodiamide—Nervous system disorder—Irinotecan—colon cancer	0.00338	0.00338	CcSEcCtD
Gadodiamide—Hyperhidrosis—Irinotecan—colon cancer	0.00333	0.00333	CcSEcCtD
Gadodiamide—Hypotension—Vincristine—colon cancer	0.00331	0.00331	CcSEcCtD
Gadodiamide—Anaphylactic shock—Fluorouracil—colon cancer	0.0033	0.0033	CcSEcCtD
Gadodiamide—Oedema—Fluorouracil—colon cancer	0.0033	0.0033	CcSEcCtD
Gadodiamide—Ataxia—Methotrexate—colon cancer	0.00329	0.00329	CcSEcCtD
Gadodiamide—Infection—Fluorouracil—colon cancer	0.00328	0.00328	CcSEcCtD
Gadodiamide—Rhinitis—Capecitabine—colon cancer	0.00326	0.00326	CcSEcCtD
Gadodiamide—Nervous system disorder—Fluorouracil—colon cancer	0.00324	0.00324	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Vincristine—colon cancer	0.00323	0.00323	CcSEcCtD
Gadodiamide—Pharyngitis—Capecitabine—colon cancer	0.00322	0.00322	CcSEcCtD
Gadodiamide—Tachycardia—Fluorouracil—colon cancer	0.00322	0.00322	CcSEcCtD
Gadodiamide—Hypotension—Irinotecan—colon cancer	0.00322	0.00322	CcSEcCtD
Gadodiamide—Urinary tract disorder—Capecitabine—colon cancer	0.00321	0.00321	CcSEcCtD
Gadodiamide—Urethral disorder—Capecitabine—colon cancer	0.00318	0.00318	CcSEcCtD
Gadodiamide—Paraesthesia—Vincristine—colon cancer	0.00318	0.00318	CcSEcCtD
Gadodiamide—Visual impairment—Capecitabine—colon cancer	0.00313	0.00313	CcSEcCtD
Gadodiamide—Paraesthesia—Irinotecan—colon cancer	0.0031	0.0031	CcSEcCtD
Gadodiamide—Hypotension—Fluorouracil—colon cancer	0.00309	0.00309	CcSEcCtD
Gadodiamide—Dyspnoea—Irinotecan—colon cancer	0.00307	0.00307	CcSEcCtD
Gadodiamide—Somnolence—Irinotecan—colon cancer	0.00306	0.00306	CcSEcCtD
Gadodiamide—Fatigue—Vincristine—colon cancer	0.00305	0.00305	CcSEcCtD
Gadodiamide—Dyspepsia—Irinotecan—colon cancer	0.00303	0.00303	CcSEcCtD
Gadodiamide—Tinnitus—Capecitabine—colon cancer	0.00303	0.00303	CcSEcCtD
Gadodiamide—Pain—Vincristine—colon cancer	0.00303	0.00303	CcSEcCtD
Gadodiamide—Flushing—Capecitabine—colon cancer	0.00301	0.00301	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00301	0.00301	CcSEcCtD
Gadodiamide—Fatigue—Irinotecan—colon cancer	0.00297	0.00297	CcSEcCtD
Gadodiamide—Paraesthesia—Fluorouracil—colon cancer	0.00296	0.00296	CcSEcCtD
Gadodiamide—Pain—Irinotecan—colon cancer	0.00295	0.00295	CcSEcCtD
Gadodiamide—Dyspnoea—Fluorouracil—colon cancer	0.00294	0.00294	CcSEcCtD
Gadodiamide—Somnolence—Fluorouracil—colon cancer	0.00294	0.00294	CcSEcCtD
Gadodiamide—Chills—Capecitabine—colon cancer	0.00291	0.00291	CcSEcCtD
Gadodiamide—Dyspepsia—Fluorouracil—colon cancer	0.00291	0.00291	CcSEcCtD
Gadodiamide—Arrhythmia—Capecitabine—colon cancer	0.0029	0.0029	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Vincristine—colon cancer	0.00289	0.00289	CcSEcCtD
Gadodiamide—Feeling abnormal—Irinotecan—colon cancer	0.00284	0.00284	CcSEcCtD
Gadodiamide—Pain—Fluorouracil—colon cancer	0.00282	0.00282	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Irinotecan—colon cancer	0.00282	0.00282	CcSEcCtD
Gadodiamide—Abdominal pain—Vincristine—colon cancer	0.0028	0.0028	CcSEcCtD
Gadodiamide—Body temperature increased—Vincristine—colon cancer	0.0028	0.0028	CcSEcCtD
Gadodiamide—Dysgeusia—Capecitabine—colon cancer	0.00277	0.00277	CcSEcCtD
Gadodiamide—Body temperature increased—Irinotecan—colon cancer	0.00273	0.00273	CcSEcCtD
Gadodiamide—Abdominal pain—Irinotecan—colon cancer	0.00273	0.00273	CcSEcCtD
Gadodiamide—Feeling abnormal—Fluorouracil—colon cancer	0.00272	0.00272	CcSEcCtD
Gadodiamide—Tremor—Capecitabine—colon cancer	0.00265	0.00265	CcSEcCtD
Gadodiamide—Renal failure—Methotrexate—colon cancer	0.00265	0.00265	CcSEcCtD
Gadodiamide—Ill-defined disorder—Capecitabine—colon cancer	0.00262	0.00262	CcSEcCtD
Gadodiamide—Urticaria—Fluorouracil—colon cancer	0.00262	0.00262	CcSEcCtD
Gadodiamide—Body temperature increased—Fluorouracil—colon cancer	0.00261	0.00261	CcSEcCtD
Gadodiamide—Hypersensitivity—Vincristine—colon cancer	0.00261	0.00261	CcSEcCtD
Gadodiamide—Malaise—Capecitabine—colon cancer	0.00255	0.00255	CcSEcCtD
Gadodiamide—Hypersensitivity—Irinotecan—colon cancer	0.00254	0.00254	CcSEcCtD
Gadodiamide—Asthenia—Vincristine—colon cancer	0.00254	0.00254	CcSEcCtD
Gadodiamide—Syncope—Capecitabine—colon cancer	0.00254	0.00254	CcSEcCtD
Gadodiamide—Loss of consciousness—Capecitabine—colon cancer	0.00248	0.00248	CcSEcCtD
Gadodiamide—Asthenia—Irinotecan—colon cancer	0.00247	0.00247	CcSEcCtD
Gadodiamide—Hypersensitivity—Fluorouracil—colon cancer	0.00243	0.00243	CcSEcCtD
Gadodiamide—Diarrhoea—Vincristine—colon cancer	0.00242	0.00242	CcSEcCtD
Gadodiamide—Myalgia—Capecitabine—colon cancer	0.00241	0.00241	CcSEcCtD
Gadodiamide—Chest pain—Capecitabine—colon cancer	0.00241	0.00241	CcSEcCtD
Gadodiamide—Arthralgia—Capecitabine—colon cancer	0.00241	0.00241	CcSEcCtD
Gadodiamide—Pharyngitis—Methotrexate—colon cancer	0.0024	0.0024	CcSEcCtD
Gadodiamide—Anxiety—Capecitabine—colon cancer	0.0024	0.0024	CcSEcCtD
Gadodiamide—Urinary tract disorder—Methotrexate—colon cancer	0.00239	0.00239	CcSEcCtD
Gadodiamide—Discomfort—Capecitabine—colon cancer	0.00238	0.00238	CcSEcCtD
Gadodiamide—Urethral disorder—Methotrexate—colon cancer	0.00237	0.00237	CcSEcCtD
Gadodiamide—Diarrhoea—Irinotecan—colon cancer	0.00236	0.00236	CcSEcCtD
Gadodiamide—Dry mouth—Capecitabine—colon cancer	0.00235	0.00235	CcSEcCtD
Gadodiamide—Dizziness—Vincristine—colon cancer	0.00234	0.00234	CcSEcCtD
Gadodiamide—Pruritus—Fluorouracil—colon cancer	0.00234	0.00234	CcSEcCtD
Gadodiamide—Visual impairment—Methotrexate—colon cancer	0.00233	0.00233	CcSEcCtD
Gadodiamide—Oedema—Capecitabine—colon cancer	0.00231	0.00231	CcSEcCtD
Gadodiamide—Infection—Capecitabine—colon cancer	0.00229	0.00229	CcSEcCtD
Gadodiamide—Dizziness—Irinotecan—colon cancer	0.00228	0.00228	CcSEcCtD
Gadodiamide—Shock—Capecitabine—colon cancer	0.00227	0.00227	CcSEcCtD
Gadodiamide—Nervous system disorder—Capecitabine—colon cancer	0.00226	0.00226	CcSEcCtD
Gadodiamide—Diarrhoea—Fluorouracil—colon cancer	0.00226	0.00226	CcSEcCtD
Gadodiamide—Tinnitus—Methotrexate—colon cancer	0.00225	0.00225	CcSEcCtD
Gadodiamide—Tachycardia—Capecitabine—colon cancer	0.00225	0.00225	CcSEcCtD
Gadodiamide—Vomiting—Vincristine—colon cancer	0.00225	0.00225	CcSEcCtD
Gadodiamide—Rash—Vincristine—colon cancer	0.00223	0.00223	CcSEcCtD
Gadodiamide—Hyperhidrosis—Capecitabine—colon cancer	0.00223	0.00223	CcSEcCtD
Gadodiamide—Dermatitis—Vincristine—colon cancer	0.00223	0.00223	CcSEcCtD
Gadodiamide—Headache—Vincristine—colon cancer	0.00222	0.00222	CcSEcCtD
Gadodiamide—Vomiting—Irinotecan—colon cancer	0.00219	0.00219	CcSEcCtD
Gadodiamide—Dizziness—Fluorouracil—colon cancer	0.00218	0.00218	CcSEcCtD
Gadodiamide—Rash—Irinotecan—colon cancer	0.00217	0.00217	CcSEcCtD
Gadodiamide—Dermatitis—Irinotecan—colon cancer	0.00217	0.00217	CcSEcCtD
Gadodiamide—Chills—Methotrexate—colon cancer	0.00217	0.00217	CcSEcCtD
Gadodiamide—Headache—Irinotecan—colon cancer	0.00216	0.00216	CcSEcCtD
Gadodiamide—Hypotension—Capecitabine—colon cancer	0.00216	0.00216	CcSEcCtD
Gadodiamide—Nausea—Vincristine—colon cancer	0.0021	0.0021	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Capecitabine—colon cancer	0.0021	0.0021	CcSEcCtD
Gadodiamide—Vomiting—Fluorouracil—colon cancer	0.0021	0.0021	CcSEcCtD
Gadodiamide—Rash—Fluorouracil—colon cancer	0.00208	0.00208	CcSEcCtD
Gadodiamide—Dermatitis—Fluorouracil—colon cancer	0.00208	0.00208	CcSEcCtD
Gadodiamide—Paraesthesia—Capecitabine—colon cancer	0.00207	0.00207	CcSEcCtD
Gadodiamide—Headache—Fluorouracil—colon cancer	0.00207	0.00207	CcSEcCtD
Gadodiamide—Dysgeusia—Methotrexate—colon cancer	0.00206	0.00206	CcSEcCtD
Gadodiamide—Dyspnoea—Capecitabine—colon cancer	0.00206	0.00206	CcSEcCtD
Gadodiamide—Nausea—Irinotecan—colon cancer	0.00205	0.00205	CcSEcCtD
Gadodiamide—Dyspepsia—Capecitabine—colon cancer	0.00203	0.00203	CcSEcCtD
Gadodiamide—Fatigue—Capecitabine—colon cancer	0.00199	0.00199	CcSEcCtD
Gadodiamide—Pain—Capecitabine—colon cancer	0.00197	0.00197	CcSEcCtD
Gadodiamide—Nausea—Fluorouracil—colon cancer	0.00196	0.00196	CcSEcCtD
Gadodiamide—Ill-defined disorder—Methotrexate—colon cancer	0.00195	0.00195	CcSEcCtD
Gadodiamide—Feeling abnormal—Capecitabine—colon cancer	0.0019	0.0019	CcSEcCtD
Gadodiamide—Malaise—Methotrexate—colon cancer	0.0019	0.0019	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Capecitabine—colon cancer	0.00189	0.00189	CcSEcCtD
Gadodiamide—Urticaria—Capecitabine—colon cancer	0.00183	0.00183	CcSEcCtD
Gadodiamide—Abdominal pain—Capecitabine—colon cancer	0.00182	0.00182	CcSEcCtD
Gadodiamide—Body temperature increased—Capecitabine—colon cancer	0.00182	0.00182	CcSEcCtD
Gadodiamide—Convulsion—Methotrexate—colon cancer	0.00182	0.00182	CcSEcCtD
Gadodiamide—Arthralgia—Methotrexate—colon cancer	0.00179	0.00179	CcSEcCtD
Gadodiamide—Chest pain—Methotrexate—colon cancer	0.00179	0.00179	CcSEcCtD
Gadodiamide—Myalgia—Methotrexate—colon cancer	0.00179	0.00179	CcSEcCtD
Gadodiamide—Discomfort—Methotrexate—colon cancer	0.00177	0.00177	CcSEcCtD
Gadodiamide—Anaphylactic shock—Methotrexate—colon cancer	0.00172	0.00172	CcSEcCtD
Gadodiamide—Infection—Methotrexate—colon cancer	0.00171	0.00171	CcSEcCtD
Gadodiamide—Hypersensitivity—Capecitabine—colon cancer	0.0017	0.0017	CcSEcCtD
Gadodiamide—Nervous system disorder—Methotrexate—colon cancer	0.00168	0.00168	CcSEcCtD
Gadodiamide—Hyperhidrosis—Methotrexate—colon cancer	0.00166	0.00166	CcSEcCtD
Gadodiamide—Asthenia—Capecitabine—colon cancer	0.00166	0.00166	CcSEcCtD
Gadodiamide—Pruritus—Capecitabine—colon cancer	0.00163	0.00163	CcSEcCtD
Gadodiamide—Hypotension—Methotrexate—colon cancer	0.00161	0.00161	CcSEcCtD
Gadodiamide—Diarrhoea—Capecitabine—colon cancer	0.00158	0.00158	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Paraesthesia—Methotrexate—colon cancer	0.00154	0.00154	CcSEcCtD
Gadodiamide—Dyspnoea—Methotrexate—colon cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Somnolence—Methotrexate—colon cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Dizziness—Capecitabine—colon cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Dyspepsia—Methotrexate—colon cancer	0.00151	0.00151	CcSEcCtD
Gadodiamide—Fatigue—Methotrexate—colon cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Pain—Methotrexate—colon cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Vomiting—Capecitabine—colon cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Rash—Capecitabine—colon cancer	0.00145	0.00145	CcSEcCtD
Gadodiamide—Dermatitis—Capecitabine—colon cancer	0.00145	0.00145	CcSEcCtD
Gadodiamide—Headache—Capecitabine—colon cancer	0.00145	0.00145	CcSEcCtD
Gadodiamide—Feeling abnormal—Methotrexate—colon cancer	0.00142	0.00142	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Methotrexate—colon cancer	0.0014	0.0014	CcSEcCtD
Gadodiamide—Nausea—Capecitabine—colon cancer	0.00137	0.00137	CcSEcCtD
Gadodiamide—Urticaria—Methotrexate—colon cancer	0.00136	0.00136	CcSEcCtD
Gadodiamide—Body temperature increased—Methotrexate—colon cancer	0.00136	0.00136	CcSEcCtD
Gadodiamide—Abdominal pain—Methotrexate—colon cancer	0.00136	0.00136	CcSEcCtD
Gadodiamide—Hypersensitivity—Methotrexate—colon cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Asthenia—Methotrexate—colon cancer	0.00123	0.00123	CcSEcCtD
Gadodiamide—Pruritus—Methotrexate—colon cancer	0.00122	0.00122	CcSEcCtD
Gadodiamide—Diarrhoea—Methotrexate—colon cancer	0.00118	0.00118	CcSEcCtD
Gadodiamide—Dizziness—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Gadodiamide—Vomiting—Methotrexate—colon cancer	0.00109	0.00109	CcSEcCtD
Gadodiamide—Rash—Methotrexate—colon cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Dermatitis—Methotrexate—colon cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Headache—Methotrexate—colon cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Nausea—Methotrexate—colon cancer	0.00102	0.00102	CcSEcCtD
